Systems and methods for ultrasound assisted lipolysis

• US 20020082589A1
• Filed: 06/11/2001
• Published: 06/27/2002
• Est. Priority Date: 12/27/2000
• Status: Active Grant

• Current Assignee: InSightec Ltd.
• Original Assignee: Insightec-Image-Guided Treatment Limited
• Inventors: Vitek, Shuki, Maor, Dov, Friedman, Zvi
• Granted Patent: US 6,645,162 B2
• Time in Patent Office: Days
• US Class Current: 606/1
• CPC Class Codes: A61B 17/22012 in direct contact with, or very close to, the obstruction or concrement for removing obstructions in blood vessels by laser A61B18/245
• CPC Class Codes: A61B 2017/22007 Cavitation or pseudocavitation, i.e. creation of gas bubbles generating a secondary shock wave when collapsing
• CPC Class Codes: A61N 2007/0008 Destruction of fat cells
• CPC Class Codes: A61N 2007/0078 with multiple treatment transducers
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092

Abstract

Cells are destroyed within a subcutaneous tissue region using a transducer disposed externally adjacent to a patient'"'"'s skin. The transducer emits acoustic energy that is focused at a linear focal zone within the tissue region, the acoustic energy having sufficient intensity to rupture cells within the focal zone while minimizing heating. The transducer may include one or more transducer elements having a partial cylindrical shape, a single planar transducer element coupled to an acoustic lens, or a plurality of linear transducer elements disposed adjacent one another in an arcuate or planar configuration. The transducer may include detectors for sensing cavitation occurring with the focal zone, which is correlated to the extent of cell destruction. A frame may be provided for controlling movement of the transducer along the patient'"'"'s skin, e.g., in response to the extent of cell destruction caused by the transducer.

Claims

1. A system for destroying tissue within a subcutaneous tissue region, comprising:

a transducer device comprising an emission surface for emitting acoustic energy, the transducer device configured for focusing the acoustic energy at a localized focal zone in the subcutaneous tissue region;

drive circuitry coupled to the transducer device for providing drive signals to the transducer device whereby the transducer device may emit acoustic energy from the emission surface; and

a controller coupled to the drive circuitry, the controller configured for controlling the drive signals delivered by the drive circuitry such that the acoustic energy emitted by the transducer device has sufficient intensity to cause mechanical damage and rupture cells within the focal zone, the controller configured for controlling the drive circuitry such that the transducer has a relatively low duty cycle to minimize heating within the focal zone.

2. The system of claim 1, wherein the drive circuitry is configured for providing drive signals having a frequency ranging from approximately 0.25 MHz to 30 MHz.

3. The system of claim 1, wherein the controller is configured for controlling the drive circuitry such that the transducer has a duty cycle of about twenty percent (20%) or less.

4. The system of claim 1, wherein the transducer device is configured for generating a substantially linear focal zone.

5. The system of claim 4, wherein the transducer device has a partial cylindrical emission surface extending substantially parallel to a longitudinal axis of the transducer.

6. The system of claim 5, wherein the transducer device comprises a substantially planar transducer element and a partial cylindrical lens defining the emission surface, the lens acoustically coupled to the planar transducer element for focusing the acoustic energy at the substantially linear focal zone.

7. The system of claim 5, wherein the emission surface is concave and has a predetermined radius of curvature for focusing the acoustic energy at a predetermined focal distance from the emission surface to the focal zone.

8. The system of claim 5, wherein the transducer device comprises one or more transducer elements disposed in an elongate arcuate configuration, the emission surface comprising an elongate concave inner surface of the one or more transducer elements.

9. The system of claim 8, wherein:

the transducer comprises a plurality of linear transducer elements disposed adjacent one another and extending substantially parallel to the longitudinal axis of the transducer;

the drive circuitry is configured for providing respective drive signals to each of the linear transducer elements; and

the controller is configured for controlling a phase of the respective drive signals to adjust a focal distance from the emission surface to the focal zone.

10. The system of claim 4, wherein the transducer comprises a plurality of elongate linear transducer elements disposed adjacent one another in a substantially planar configuration.

11. The system of claim 10, wherein the drive circuitry is configured for providing respective drive signals to each of the linear transducer elements, and wherein the controller is configured for controlling a phase of the respective drive signals to adjust a focal distance from the emission surface to the focal zone.

12. The system of claim 4, wherein the transducer device comprises a plurality of transducers disposed adjacent to one another, the transducers configured for generating respective substantially linear focal zones that extend generally parallel to one another.

13. The system of claim 12, wherein a first of the plurality of transducers has a first focal distance and wherein a second of the plurality of transducers has a second focal distance that is different than the first focal distance.

14. The system of claim 1, further comprising a frame to which the transducer device is mounted, the transducer device being movable along the frame for moving the focal zone to successive tissue regions.

16. The method of claim 15, wherein the acoustic energy has sufficient intensity to vibrate the cells within the focal zone with sufficient mechanical energy to cause the cells to rupture.

17. The method of claim 15, wherein the acoustic energy has a frequency ranging from approximately 0.25 MHz to 30 MHz.

18. The method of claim 15, wherein the transducer defines a longitudinal axis, and wherein the focal zone comprises a substantially linear focal zone extending substantially parallel to the longitudinal axis.

19. The method of claim 17, wherein the transducer comprises an acoustic emission surface defining a portion of a cylinder for focusing the acoustic energy at the substantially linear focal zone.

20. The method of claim 19, wherein the transducer comprises a plurality of transducer elements disposed substantially parallel to the longitudinal axis, and wherein the step of driving the transducer comprises controlling a phase of the drive signals to adjust a focal distance to the focal zone.

21. The method of claim 19, wherein the transducer comprises a generally planar transducer and an acoustic lens defining the emission surface, and wherein the acoustic energy is focused at the focal zone by directing the acoustic energy through the acoustic lens.

22. The method of claim 19, wherein the transducer comprises an arcuate transducer extending substantially parallel to the longitudinal axis.

23. The method of claim 18, further comprising moving the transducer in a direction substantially perpendicular to the longitudinal axis of the transducer, thereby moving the focal zone to a position substantially parallel to a previous position within the tissue region.

24. The method of claim 23, wherein the transducer is mounted to a frame, the transducer being movable along the frame in a direction substantially perpendicular to the longitudinal axis of the transducer.

25. The method of claim 15, wherein the acoustic energy has sufficient intensity to cavitate the cells within the focal zone.

26. The method of claim 25, further comprising introducing a fluid into the tissue region, the fluid comprising gas bubbles for enhancing cavitation within the tissue region.

27. The method of claim 25, further comprising monitoring cavitation within the focal zone;

correlating the cavitation within the focal zone with an extent of cell destruction within the focal zone; and

automatically moving the transducer to a new location along the external surface of the patient when a predetermined level of cell destruction within the focal zone is obtained.

28. The method of claim 27, wherein the cavitation is monitored by one or more cavitation detectors.

29. The method of claim 28, wherein the cavitation detectors comprise acoustic sensors that produce signals in response to cavitation within the focal zone, and wherein the signals are compared to a database to correlate the cavitation occurring within the focal zone to the extent of cell destruction.

30. The method of claim 29, wherein a rate of change in amplitude of the signals is correlated with an empirical database to determine when the predetermined level of cell destruction is obtained.

15. A method for destroying cells within a subcutaneous tissue region located beneath a patient'"'"'s skin, comprising:

disposing a transducer externally adjacent to the patient'"'"'s skin; and

driving the transducer with drive signals using a relatively low duty cycle such that the transducer emits acoustic energy, while focusing the acoustic energy from the transducer at a localized focal zone within the tissue region, the acoustic energy having sufficient intensity to rupture cells within the focal zone while substantially minimizing heating of tissue within the focal zone.